Whilst not officially listed as a common side effect, our patients taking GLP-1 receptor agonist injections have often reported increased hair loss during treatment
Encouraging normal sperm production*
Muscle loss is a documented risk during GLP-1 (Wegovy and Zepbound) use that requires active clinical management, not just weight tracking
Additionally, P53 can inhibit cystine uptake through downregulation of SLC7A11 expression within the Xc system, affecting GPX4 activity which leads to reduced cellular antioxidant capacity, accumulation of lipid ROS, and ferroptosis [32, 33]
Initially developed for type 2 diabetes, they are now recognized for their broad impact on weight regulation, inflammation, cardiovascular health, and neuroprotectiondomains central to longevity and healthy aging
How does Ozempic work in the body to promote weight loss